These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 1540294)
1. Allergenic potency of SMU-Df extract in comparison with VUS-Df extract; and diagnosis and immunotherapy for atopic dermatitis and rhinitis with SMU-Df extract in China. Wen T; Wang E; Shen S; Jiang C; Tian R; Kang K; Zhu J Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1992; (85):217-27. PubMed ID: 1540294 [No Abstract] [Full Text] [Related]
2. [Safety analysis of dust mite allergen for diagnosis and immunotherapy of asthma and rhinitis]. Wen T; Cai Y; Chen X; Xiang L; Wang B; Zhuang Y Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(5):274-6. PubMed ID: 12563856 [TBL] [Abstract][Full Text] [Related]
3. Dermatophagoides farinae mite allergen and specific immunotherapy in Shanghai. Wen TH Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Oct; 27(5):419-25. PubMed ID: 20066974 [TBL] [Abstract][Full Text] [Related]
4. Intranasal immunotherapy with Dermatophagoides extract: in vivo and in vitro results of a double-blind placebo-controlled trial. Fanales-Belasio E; Ciofalo A; Zambetti G; Ansotegui IJ; Scala E; Paganelli R; Filiaci F Rhinology; 1995 Sep; 33(3):126-31. PubMed ID: 8560161 [TBL] [Abstract][Full Text] [Related]
5. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. Pajno GB; Caminiti L; Vita D; Barberio G; Salzano G; Lombardo F; Canonica GW; Passalacqua G J Allergy Clin Immunol; 2007 Jul; 120(1):164-70. PubMed ID: 17543376 [TBL] [Abstract][Full Text] [Related]
6. Dermatophagoides farinae-specific immunotherapy in atopic dogs with hypersensitivity to multiple allergens: a randomised, double blind, placebo-controlled study. Willemse T; Bardagi M; Carlotti DN; Ferrer L; Fondati A; Fontaine J; Leistra M; Noli C; Ordeix L; Scarampella F; Schleifer S; Sinke J; Roosje P Vet J; 2009 Jun; 180(3):337-42. PubMed ID: 18653361 [TBL] [Abstract][Full Text] [Related]
7. [The efficacy of long-term specific immunotherapy for Dermatophagoides pteronyssinus in patients with atopic dermatitis]. Pacor ML; Biasi D; Maleknia T Recenti Prog Med; 1994 May; 85(5):273-7. PubMed ID: 8023005 [TBL] [Abstract][Full Text] [Related]
8. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study]. Silny W; Czarnecka-Operacz M Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of immune parameters (including specific IgG4) during immunotherapy. Ruiz de León Loriga J; Lluch Pérez M; Valero Santiago A; Zamorano Calderón M; Huguet Casals J; Malet Casajuana A; García Calderón PA Allergol Immunopathol (Madr); 1989; 17(3):119-27. PubMed ID: 2479244 [TBL] [Abstract][Full Text] [Related]
10. Atopy patch test reactions to house dust mites in patients with scabies. Taşkapan O; Harmanyeri Y Acta Derm Venereol; 2005; 85(2):123-5. PubMed ID: 15823904 [TBL] [Abstract][Full Text] [Related]
11. Treatment of atopic dermatitis with a combination of allergen-specific immunotherapy and a histamine-immunoglobulin complex. Nahm DH; Lee ES; Park HJ; Kim HA; Choi GS; Jeon SY Int Arch Allergy Immunol; 2008; 146(3):235-40. PubMed ID: 18268392 [TBL] [Abstract][Full Text] [Related]
12. Reproducibility of atopy patch tests with Dermatophagoides: a study on 85 patients with atopic dermatitis. Giusti F; Seidenari S Contact Dermatitis; 2004 Jan; 50(1):18-21. PubMed ID: 15059098 [TBL] [Abstract][Full Text] [Related]
13. Antigens and allergens in Dermatophagoïdes farinae mite. I. Immunochemical and physicochemical study of two allergenic fractions from a partially-purified Dermatophagoïdes farinae mite extract. Le Mao J; Dandeu JP; Rabillon J; Lux M; David B Immunology; 1981 Oct; 44(2):239-47. PubMed ID: 7298067 [TBL] [Abstract][Full Text] [Related]
14. Specific immunotherapy design questions. Moed H; de Bot C; van der Wouden JC Allergy; 2006 Jul; 61(7):896. PubMed ID: 16792592 [No Abstract] [Full Text] [Related]
15. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study. Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407 [TBL] [Abstract][Full Text] [Related]
17. Use of a specific oral hyposensitization therapy to Dermatophagoides pteronyssinus in children with atopic dermatitis. Galli E; Chini L; Nardi S; Benincori N; Panei P; Fraioli G; Moschese V; Rossi P Allergol Immunopathol (Madr); 1994; 22(1):18-22. PubMed ID: 8030579 [TBL] [Abstract][Full Text] [Related]
18. [The diagnosis and treatment of allergic diseases caused by sensitization to the Dermatophagoides farinae mite]. Golysheva MA; Berzhets VM; Pakhomova LA; Emel'ianova OIu Ter Arkh; 1989; 61(10):130-1. PubMed ID: 2609258 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study. Tari MG; Mancino M; Monti G Allergol Immunopathol (Madr); 1990; 18(5):277-84. PubMed ID: 2097894 [TBL] [Abstract][Full Text] [Related]
20. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Werfel T; Breuer K; Ruéff F; Przybilla B; Worm M; Grewe M; Ruzicka T; Brehler R; Wolf H; Schnitker J; Kapp A Allergy; 2006 Feb; 61(2):202-5. PubMed ID: 16409197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]